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httpHybrid treatment of an aortic pseudoaneurysm
arising at the innominate artery junction secondary
to superior vena cava stenting
Arnaud Roussel, MD, Dominique Fabre, MD, Elie Fadel, MD, PhD, Claude Angel, MD, and
Philippe Dartevelle, MD, PhD, Le Plessis-Robinson, France
Pseudoaneurysm of the innominate artery secondary to superior vena cava stenting has never been reported. We report
the case of a 42-year-old woman previously treated for a Masaoka stage III thymoma with superior vena cava replacement
through median sternotomy followed by adjuvant radiation therapy. Four years later, the patient came back with a large
pseudoaneurysm at the junction of the innominate artery and ascending aorta. To avoid resternotomy, endovascular
deployment of a stent graft in the ascending aorta with a periscope stenting in the left common carotid artery after
axilloaxillary bypass was performed to treat this aortic pseudoaneurysm. (J Vasc Surg Cases 2015;1:127-9.)Aortic pseudoaneurysm arising at the innominate ar-
tery junction is a rare occurrence. The usual causes include
traumatic and iatrogenic causes, but superior vena cava
(SVC) stenting has not been previously reported. We
report a case of closure of a pseudoaneurysm of the junc-
tion of the innominate artery and the aorta secondary to
SVC stenting with hybrid treatment.
CLINICAL PRESENTATION
A 42-year-old woman was admitted with an innominate
artery pseudoaneurysm resulting from SVC stenting. She was
previously operated on for a Masaoka stage III thymoma
through median sternotomy by wedge resection of the right
upper and middle lobe, thymomectomy, and bypass grafting
(polytetraﬂuoroethylene vascular graft) between the left
innominate vein and right atrium followed by adjuvant radi-
ation therapy (60 Gy). One year later, she presented with
acute SVC syndrome resulting from thrombosis of the
bypass graft because she stopped her anticoagulation treat-
ment. She underwent a retrograde recanalization with a
nitinol self-expandable uncovered stent (Luminexx; Bard,
Salt Lake City, Utah) and two nitinol self-expandable
covered stents (Fluency, Bard). Ten months later, she pre-
sented with a recurrent intrastent thrombosis with SVC syn-
drome treated with anticoagulation therapy. Four years afterthe Department of Thoracic and Vascular Surgery, Marie Lanne-
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The ﬁndings on ﬁbroscopy were normal. The computed to-
mography scan showed a 25  35-mm pseudoaneurysm at
the junction of the innominate artery and aortic arch result-
ing from a large ulceration secondary to bypass graft stenting
(Figs 1 and 2). The patient’s consent to publish data has
been obtained.
PROCEDURE
In the hybrid operating room, under general anes-
thesia, a left to right axilloaxillary bypass was performed us-
ing a prosthetic polytetraﬂuoroethylene 7-mm graft
(Distaﬂo, Bard) by two end-to-side anastomoses. Bypass
tunnelization was performed underneath the skin under
videoscopic control to prevent any venous bleeding.
Through the right brachial artery, angiography was
performed using a 5F pigtail catheter (Cook Inc,
Bloomington, Ind) advanced into the ascending aorta.
Through right femoral access, a 260-cm, 0.035-inch
guidewire (Terumo Medical Corporation, Tokyo, Japan)
was placed under ﬂuoroscopic control into the ascending
aorta and replaced by a stiff guidewire (Starter; Boston Sci-
entiﬁc, Galway, Ireland), and the aortic stent graft (Valiant;
Medtronic Vascular, Santa Rosa, Calif) was delivered in the
ascending aorta. The proximal and distal landing zones
were, respectively, 54 mm and 22 mm. A homemade
endograft (diameter, 32 mm; length, 150 mm) shortened
to 65 mm was used.
Through left femoral access, a 260-cm, 0.035-inch
guidewire (Terumo Medical Corporation) was placed under
ﬂuoroscopic control into the left common carotid; a 4F cath-
eter (Glidecath, Terumo) was advanced into the left com-
mon carotid over the guidewire. This catheter was used to
exchange the guidewire for a stiff guidewire (Starter). A
10-  80-mm self-expandable covered stent (Fluency) was
used for the left carotid retrograde revascularization.
The stent graft (Valiant) and the self-expandable
covered stent (Fluency) were deployed simultaneously un-
der ﬂuoroscopic control using an antegrade periscope127
Fig 1. Preoperative computed tomography scan. Thin arrow,
Superior vena cava (SVC) stent. Thick arrow, Pseudoaneurysm
arising from the junction of the innominate artery and aorta.
Fig 2. Preoperative angiogram. Arrow, Pseudoaneurysm arising
from the junction of the innominate artery and aorta.
Fig 3. Postoperative baseline angiogram showing patency of
axilloaxillary bypass and left common carotid covered stent and
exclusion of pseudoaneurysm.
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origin of the coronary arteries and the origin of the left sub-
clavian artery. Ballooning was performed in the carotid
stent using a 9-mm balloon (Fox Plus; Abbott, Santa Clara,
Calif).
Occlusion of the innominate artery was performed
through the right subclavian artery with a coil embolization
(Interlock, 14 mm  30 cm; Boston Scientiﬁc) and deploy-
ment of a 16  8-mm plug (Amplatzer; AGA Medical Cor-
poration, Plymouth, Minn) in the origin of the innominate
artery. A baseline angiogram was obtained to conﬁrm
proper position of the stent graft, patency of the common
carotid covered stent and axilloaxillary bypass, andcomplete exclusion of the lesion (Fig 3). The patency of
the vascular reconstruction was conﬁrmed by computed to-
mography scan at 18 months.
DISCUSSION
SVC syndrome is an obstruction of ﬂow through the
SVC caused by a variety of malignant or benign entities.1
Treatment by percutaneous delivery of metallic stents was
initially reported in 1986 and since then has been used
extensively.2 Successful stent deployment generally results
in restoration of laminar blood ﬂow with early resolution
of symptoms and long-term patency of the SVC.3,4 Gwon
et al5 showed that endovascular polytetraﬂuoroethylene-
covered stents seemed to be superior to uncovered stents
in terms of stent patency. However, the covered and uncov-
ered stents did not differ signiﬁcantly in terms of patient sur-
vival and clinical success. Complications are uncommon, and
few have been reported. These include migration or
misplacement of the stent, thrombotic stent occlusion,
puncture of the right atrium, pericardial tamponade, pulmo-
nary edema, rupture of the SVC, and laceration of the
aorta.6-9 We believe that this case is the ﬁrst documented
case of innominate artery pseudoaneurysm secondary to
SVC stenting.
Pseudoaneurysms generally develop when there is a
disruption in the continuity of the arterial wall resulting
from traumatic or iatrogenic causes, biopsy and catheteri-
zation being the most frequent of the latter.10 Despite their
scarcity, pseudoaneurysms of the supra-aortic arteries carry
a signiﬁcant risk of disabling neurologic symptoms or
death.11 Our patient presented with a pseudoaneurysm
arising from the junction of the innominate artery and
the aorta.
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a median sternotomy with or without cardiopulmonary
bypass and induced hypothermia. Even in the hands of
an experienced surgeon, there is considerable morbidity
and mortality related to open repeated surgical repair.12
The emergence of endovascular treatments therefore pre-
sents an alternative to the conventional surgical treatment
of pseudoaneurysms arising from the origin of the innom-
inate artery and the aorta. Percutaneous closure of aortic
pseudoaneurysm by an occluder device has already been
described. Technical considerations include the pseudoa-
neurysm neck measurement, which inﬂuences the choice
of device, and the presence of infection, which should pre-
clude the use of an implanted device. Complications
include pseudoaneurysm rupture, device migration, and
recurrence.13 The history of previous surgery through me-
dian sternotomy with adjuvant mediastinal radiation ther-
apy led us to avoid resternotomy and to choose a hybrid
approach. To provide an appropriate landing zone for the
aortic stent graft and to preserve perfusion to the supra-
aortic trunks, we performed an axilloaxillary bypass and a
left common carotid artery stenting described as the peri-
scope technique.
The periscope technique is used to extend the distal
landing zone during endovascular treatment. This tech-
nique has proved to be a feasible, safe, and effective way
to treat thoracoabdominal aneurysms.14 Nevertheless, peri-
operative complications, such as dislocated stent graft, sig-
niﬁcant pressure gradient in the branch device requiring
additional balloon inﬂation or stenting, and type I endo-
leak, have been described.15 Furthermore, there are some
limitations to this technique: patency of iliac arteries, diam-
eter of aorta $16 mm (periscope graft is perfused in a
retrograde manner and depends on distal aortic perfusion),
diameter of target artery $4 mm with a landing zone
$1 cm, and high-end imaging tools are required.15CONCLUSIONS
This case report demonstrates that hybrid treatment
can be safely and effectively used to treat pseudoaneurysms
at the junction of the innominate artery and aortic arch in a
minimally invasive manner. Long-term follow-up will be
necessary to ensure that the favorable early outcome that
we obtained is durable.REFERENCES
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